Safety Alerts & Recalls
What does this mean?
These insulin products will remain available through pharmacies until current supplies are depleted. If you are using any of the insulin products listed above, please make an appointment with your doctor so that you can be switched to a different insulin therapy. If you have any other questions about your insulin therapy, please follow up with your doctor or pharmacist.
Discontinuation of Lilly Humulin 50/50 and Select NovoNordisk Insulin Delivery Devices
Eli Lilly and Company and NovoNordisk, Inc have announced that they will be stop making select insulin products.
1) HUMULIN 50/50 - Eli Lilly and Company has decided to stop producing Humulin 50/50 because the use of this insulin has been declining. Based on the current stock of Humulin 50/50, Lilly anticipates this insulin formulation should be available at pharmacies until the end of April 2010.
2) NOVOLIN INNOLET disposable insulin pens and NOVOLIN PENFILL 3 mL insulin cartridges - Novo Nordisk, Inc is discontinuing several insulin delivery devices listed below. After this discontinuation, pharmacies may continue to stock Novolin InnoLet disposable insulin pens and Novolin PenFill 3mL insulin cartridges, but they will not receive any new inventory. The final date of sale of the products is December 31, 2009.
The discontinued NovoNordisk products: Novolin R InnoLet (Regular, Human Insulin Injection in a 3 mL disposable prefilled insulin syringe)
Novolin N InnoLet (NPH, Human Insulin Isophane Suspension in a 3 mL disposable prefilled insulin syringe)
Novolin 70/30 InnoLet (70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection in a 3 mL disposable prefilled insulin syringe)
Novolin R PenFill 3 mL cartridges (Regular, Human Insulin Injection)
Novolin N PenFill 3 mL cartridges (NPH, Human Insulin Isophane Suspension)
Novolin 70/30 PenFill 3 mL cartridges (70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection)
For more information, please visit: more information here